EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in the fine specificities of monoclonal (Class A) antibodies to human myeloid cells


Clinical and Experimental Immunology 60(1): 151-158
Differences in the fine specificities of monoclonal (Class A) antibodies to human myeloid cells
Among 13 monoclonal antibodies to human myelomonocytic cells, six could be assigned to a group designated Class A with the following properties: (a) they react almost exclusively with granulocytes among cells of the peripheral blood, (b) they resemble the previously described anti-granulocyte antibodies, VEP8 and VEP9, and the anti-mouse embryo, anti-SSEA-1, in their strong reactions with human meconium glycoproteins and ovarian cyst mucins of non-secretor type and (c) they recognize the carbohydrate antigen 3-fucosyl-N-acetyllactosamine (alpha 1----3fucosylated Type 2 blood group chains). The binding of these anti-myeloid antibodies is more strongly inhibited by lacto-N-fucopentaose III than by the trisaccharide-fucosyl-N-acetyllactosamine, in contrast to anti-SSEA-1 which is more strongly inhibited by the trisaccharide. These observations suggest that the myeloid Class A antibodies recognize additional determinants on the neolacto (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4) backbone of the pentasaccharide which occurs on the glycoproteins and glycolipids of myeloid cells. However, no two of the anti-myeloid antibodies were identical in their inhibition patterns with the glycoproteins and the two oligosaccharides. They also differed in their cellular reactivities, for example, the proportion of cells in the K-562 cell line reacting with each antibody ranged from 15-57%.

(PDF 0-2 workdays service: $29.90)

Accession: 005151278

PMID: 2408796



Related references

Heteroclitic antibodies: differences in fine specificities between monoclonal antibodies directed against dinitrophenyl and trinitrophenyl haptens. International Archives of Allergy and Applied Immunology 85(2): 238-243, 1988

Differences in the characteristics of human monoclonal and polyclonal anti-D as revealed by immunochemical investigations: human monoclonal antibodies share specificities with natural antibodies. Transfusion Medicine 2(2): 151-157, 1992

Structural differences among monoclonal antibodies with distinct fine specificities and kinetic properties. Molecular Immunology 36(17): 1189-1205, 2000

Structural differences among monoclonal antibodies with distinct fine specificities and kinetic properties. Molecular Immunology 36(17): 1189-1205, Dec, 1999

Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells. Immunogenetics 32(1): 51-55, 1990

Analysis of the fine specificities of sheep major histocompatibility complex class II-specific monoclonal antibodies using mouse L-cell transfectants. Animal Genetics 26(2): 79-84, 1995

Interpretation of the specificities of monoclonal antibodies recognising human MHC class II antigens. Clinical and Experimental Immunology 59(1): 251-254, 1985

Interpretation of the specificities of monoclonal antibodies recognizing human major histocompatibility class ii antigens. Clinical & Experimental Immunology 59(1): 251-254, 1985

Analysis of sequential immunoprecipitations of the specificities of the monoclonal antibodies tu 22 34 35 36 37 39 43 58 and yd 1 63 hlk directed against human hla class ii antigens. Immunobiology 171(1-2): 77-92, 1986

Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens. Immunobiology 171(1-2): 77-92, 1986